Wanlian Securities Supports “Guangzhou’s First Chip” in Its Listing on ChiNext, as Patient Capital Fuels the Development of China’s Hard-Tech Sector
Wanlian Securities Recently, CanSemi Technology Inc. was officially listed on the ChiNext Market of the Shenzhen Stock Exchange, marking the culmination of nearly a decade of patient-capital investment by Wanlian Securities. In 2017, Wanlian Tianze Capital Investment Co., Ltd., a subsidiary of Wanlian Securities, took the lead in establishing the Yuxin Fund, which became CanSemi’s […]
